NL7601132A - IMMUNOLOGICAL MATERIALS. - Google Patents

IMMUNOLOGICAL MATERIALS.

Info

Publication number
NL7601132A
NL7601132A NL7601132A NL7601132A NL7601132A NL 7601132 A NL7601132 A NL 7601132A NL 7601132 A NL7601132 A NL 7601132A NL 7601132 A NL7601132 A NL 7601132A NL 7601132 A NL7601132 A NL 7601132A
Authority
NL
Netherlands
Prior art keywords
bonds
molecules
gps
forming
covalently bonded
Prior art date
Application number
NL7601132A
Other languages
Dutch (nl)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4695/75A external-priority patent/GB1496011A/en
Application filed by Searle & Co filed Critical Searle & Co
Publication of NL7601132A publication Critical patent/NL7601132A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

Cytotoxic agents (I) comprise an immunoglobulin (Ig), specific for the antigens on the surface of the cells which it is intended to kill, to which are covalently bonded 1-10 molecules of a polymeric carrier (VP) having covalently bonded to them in turn 5-500 molecules of a cytotoxic medicament (CD). (VP) has mol. wt. 5000-500000 and contains COOH, NH2 or cycloimidocarbonate gps. for forming the covalent bonds, and (CD) also has NH2 or COOH gps. for forming these bonds. Used for treating neoplastic diseases. The CD/VP bonds are enzymatically cleared when (I) is attached to the target cell, so by use of particular Ig, large amts. of (CD) can be delivered to specific points. The toxicity of (CD) is much lower when bonded in (I) than when used as the free cpd.
NL7601132A 1975-02-04 1976-02-04 IMMUNOLOGICAL MATERIALS. NL7601132A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4695/75A GB1496011A (en) 1974-11-22 1975-02-04 Defoaming composition

Publications (1)

Publication Number Publication Date
NL7601132A true NL7601132A (en) 1976-08-06

Family

ID=9782062

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7601132A NL7601132A (en) 1975-02-04 1976-02-04 IMMUNOLOGICAL MATERIALS.

Country Status (5)

Country Link
JP (1) JPS51126281A (en)
BE (1) BE838273A (en)
DK (1) DK43676A (en)
NL (1) NL7601132A (en)
SE (1) SE7601125L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57143326A (en) * 1981-03-03 1982-09-04 Teijin Ltd Polymer linked to cellular toxic substance and its preparation
DE3205847A1 (en) * 1981-05-08 1982-12-16 Farmitalia Carlo Erba S.p.A., 20159 Milano Daunorubicin-protein conjugates
JPS60172935A (en) * 1984-02-16 1985-09-06 Green Cross Corp:The Preparation of composite material of substance having carcinostatic action
JPS611622A (en) * 1984-06-14 1986-01-07 Teijin Ltd Cytotoxic complex and preparation thereof
FR2586564B1 (en) * 1985-09-04 1989-04-07 Pierre Tran Ba Loc IMMUNOSUPPRESSIVE COMPOUNDS AND PROCESS FOR THEIR PREPARATION
JPS62228025A (en) * 1985-12-27 1987-10-06 Teijin Ltd Production of antibody complex
DE3788058T2 (en) * 1986-08-28 1994-04-21 Teijin Ltd CELL TOXIC ANTIBODY COMPLEX AND METHOD FOR THE PRODUCTION THEREOF.
JPH0662438B2 (en) * 1986-08-28 1994-08-17 帝人株式会社 Cytotoxic antibody conjugate and method for producing same
US5149782A (en) * 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
JP2626654B2 (en) * 1990-03-31 1997-07-02 科学技術振興事業団 Targeting high molecular weight pharmaceutical compounds and intermediates thereof

Also Published As

Publication number Publication date
DK43676A (en) 1976-08-05
SE7601125L (en) 1976-08-05
JPS51126281A (en) 1976-11-04
BE838273A (en) 1976-08-04

Similar Documents

Publication Publication Date Title
NL7601132A (en) IMMUNOLOGICAL MATERIALS.
ATE2113T1 (en) PROCESS FOR THE MANUFACTURE OF SOLID PHARMACEUTICALS WITH ACTIVE INGREDIENTS APPLIED IN DROPS.
DD129788A5 (en) PROCESS FOR THE PREPARATION OF 3 ', 3' ', 5', 5 '' - TETRACHLORPHENOL-3,4,5,6-TETRABROMSULFOPHTHALENE IN BZW.3 ', 3' '- DIBROM-5', 5 '' - DICHLORPHENOL-3 , 4,5,6-TETRACHLORSULFOPHTHALEIN
ATE199741T1 (en) GENE THERAPEUTICAL TREATMENT OF TUMORS WITH AN ENDOTHELIAL CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
NL186634C (en) PROCESS FOR THE PREPARATION OF CYCLIC AMINO ACIDS AND FOR PREPARATION OF SULFONYLOXYIMIDES SUITABLE FOR THE USE OF THIS PROCESS
ATE198354T1 (en) PROTEIN TRACKING ON HIV VIRION BASED ON HIV-1 VPR FUSION MOLECULES
DE3471663D1 (en) Macromolecular carbonyl groups-containing material suitable for use as sorbent for urea
NL162080B (en) PROCESS FOR THE PREPARATION OF N- (PERFLUORACYL) -N-PHOSPHONOMETHYL GLYCINES.
NL175435C (en) PROCESS FOR PREPARING OPTICALLY ACTIVE AMINO ACID COMPOUNDS.
SE8008096L (en) SET TO BIND A PROTEIN TO A CARRIER CONTAINING HYDROXYL GROUPS
NL7703524A (en) PREPARATIONS BASED ON ALKENYL SUCCINIMIDE DERIVATIVES OF N.N.N'N'-TETRAKIS (3-AMINOPROPYL) ETHYLENE DIAMINE.
ATE59554T1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON MERCAPTOETHANESULPHONIC ACIDS, ORGANIC DERIVATIVES OF MERCAPTOETHANESULPHONIC ACIDS AND PROCESSES FOR THEIR PREPARATION.
SE7701894L (en) BIOLOGICALLY ACTIVE POLYMERS
ES455708A2 (en) A PROCEDURE TO RAISE THE INTRAVENOUS TOLERANCE OF GAMMA GLOBULINS PRECIPITATED FROM THE BLOOD OR BLOOD PRODUCTS.
IT1084648B (en) DRIVING DEVICE PERFECTED FOR THE SHARPENING OF SAWS.
ATE59143T1 (en) COMPOSITION FOR TRANSDERMAL DRUG DELIVERY.
ATA1015273A (en) PROCESS FOR THE PREPARATION OF NEW (1,4) DITIHIINO (2,3-C) PYRROL DERIVATIVES AND THEIR ACID ADDITION SALTS
NL7706090A (en) PROCESS FOR THE PREPARATION OF (ALPHA) - (4'-ALKYL-PHENYL) ALKANE CARBON ACIDS.
FR2183679A1 (en) Modified immunoserumglobulin prepns - for intravenous injection-selective redn with dithiothreitol and alkylation-free from
AT348507B (en) METHOD FOR MANUFACTURING RACEMIC AND OPTICALLY ACTIVE 1-TERT. BUTYLAMINO-3- (2 ', 5'-DICHLOROPHENOXY) -2-PROPANOL AND ITS ACID ADDITION SALT
NL7412336A (en) PROCESS FOR THE PREPARATION OF CARBONIC ACID GROUPS-CONTAINING HYDROCARBON RESINS AND THEIR USE AS A BINDING AGENT.
SU640003A1 (en) Butt joint
SE8904397D0 (en) MAKE COVALENT BINDING PROTEINS FOR HYDROFILA Y TOR
SU608653A2 (en) Apparatus for recovery of polymer materials from their solutions
SU861004A1 (en) Apparatus for piecewise delivering of parts

Legal Events

Date Code Title Description
BV The patent application has lapsed